Alba Therapeutics announces following clinical trial of lead compound, Larazotide Acetate Alba Therapeutics Company announced today it’ll initiate further clinical studies for patients diagnosed with celiac disease with their business lead substance, larazotide acetate. ‘Our most recent Phase IIb research, the biggest trial with an investigational medication conducted in patients with celiac disease, was a randomized, double-blind, placebo controlled, dosage ranging, multicenter research to look for the safety, tolerance and efficacy of larazotide acetate in 184 adults with managed celiac disease throughout a gluten challenge.The next 20 home-related products represent the categories contributing to the highest number of estimated mind injuries treated in 2008, all ages. Keep one hand on the baby while changing diapers. Aetna Entire Health plans create a unique opportunity for Roanoke-area businesses to help their employees optimize their health insurance and get healthier quicker. Aetna can be using the experience we’ve gained to design patient-centered, accountable care models for large hospital systems and included delivery networks around the national country. Aetna Whole Health programs unite Aetna’s network of contracted providers and small-group plans with doctors, outpatient and hospitals specialty centers from Carilion Clinic and LewisGale Regional Health System.